Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Assets (2016 - 2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Return on Assets for 15 consecutive years, with 0.16% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 76.0% year-over-year to 0.16%, compared with a TTM value of 0.16% through Dec 2025, up 76.0%, and an annual FY2025 reading of 0.02%, up 66.0% over the prior year.
  • Return on Assets was 0.16% for Q4 2025 at Arrowhead Pharmaceuticals, up from 0.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.16% in Q4 2025 and bottomed at 0.6% in Q1 2024.
  • Average Return on Assets over 5 years is 0.26%, with a median of 0.2% recorded in 2022.
  • The sharpest move saw Return on Assets crashed -43bps in 2024, then skyrocketed 76bps in 2025.
  • Year by year, Return on Assets stood at 0.27% in 2021, then grew by 28bps to 0.2% in 2022, then plummeted by -122bps to 0.44% in 2023, then tumbled by -39bps to 0.6% in 2024, then surged by 126bps to 0.16% in 2025.
  • Business Quant data shows Return on Assets for ARWR at 0.16% in Q4 2025, 0.02% in Q3 2025, and 0.11% in Q2 2025.